| PATHWAY_NAME |
REACTOME_ID |
KEGG_ID |
DRUG_NAME |
PUBCHEM_CID |
Datasource |
| Pro-survival signaling of neuroprotectin D1 |
R-HSA-75824 |
0 |
Neuroprotectin D1 |
65096 |
pubchem |
| GPCRs, class A rhodopsin-like |
R-HSA-373076 |
0 |
Somatostatine |
65110 |
pubchem |
| Bile Acid Direct Signalling Pathway |
#N/A |
#N/A |
Glucagon-like peptide 1 |
65127 |
pubchem |
| Pancreas Function - Beta Cell |
R-HSA-9762292 |
0 |
Glucagon-like peptide 1 |
65127 |
pubchem |
| Disease |
R-HSA-1643685 |
0 |
Ivacaftor |
65359 |
pubchem |
| Disorders of transmembrane transporters |
R-HSA-5619115 |
0 |
Ivacaftor |
65359 |
pubchem |
| ABC transporter disorders |
R-HSA-5619084 |
0 |
Ivacaftor |
65359 |
pubchem |
| Defective CFTR causes cystic fibrosis |
R-HSA-5678895 |
0 |
Ivacaftor |
65359 |
pubchem |
| Ivacaftor pathway, pharmacokinetics |
R-ALL-5678956 |
0 |
Lumacaftor |
16678941 |
pubchem |
| Orf10 Cul2 pathway |
#N/A |
#N/A |
Pevonedistat |
65399 |
pubchem |
| Salicylate-Sodium Action Pathway |
R-HSA-9639775 |
0 |
Sodium Salicylate |
16760658 |
pubchem |
| Drug ADME |
R-HSA-9748784 |
0 |
Atorvastatin(1-) |
65981 |
pubchem |
| Atorvastatin ADME |
R-HSA-9754706 |
0 |
Atorvastatin(1-) |
65981 |
pubchem |
| Alcaftadine H1-Antihistamine Action |
R-HSA-9639775 |
0 |
Alcaftadine |
19371515 |
pubchem |
| Heparin Action Pathway |
R-ALL-9835132 |
0 |
(2S,3S,4R,5R,6R)-6-{[(2S,3S,4S,5R,6S)-6-{[(2R,3S,4S,5R)-2-carboxy-4,6-dihydroxy-5-(sulfooxy)oxan-3-yl]oxy}-2-hydroxy-4-(sulfomethyl)-5-(sulfooxy)oxan-3-yl]oxy}-3-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-4,5-dihydroxy |
66414 |
pubchem |
| Fc Epsilon Receptor I Signaling in Mast Cells |
R-HSA-2454202 |
0 |
(2S,3S,4R,5R,6R)-6-{[(2S,3S,4S,5R,6S)-6-{[(2R,3S,4S,5R)-2-carboxy-4,6-dihydroxy-5-(sulfooxy)oxan-3-yl]oxy}-2-hydroxy-4-(sulfomethyl)-5-(sulfooxy)oxan-3-yl]oxy}-3-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-4,5-dihydroxy |
66414 |
pubchem |
| 22q11.2 copy number variation syndrome |
R-HSA-2206302 |
0 |
(2S,3S,4R,5R,6R)-6-{[(2S,3S,4S,5R,6S)-6-{[(2R,3S,4S,5R)-2-carboxy-4,6-dihydroxy-5-(sulfooxy)oxan-3-yl]oxy}-2-hydroxy-4-(sulfomethyl)-5-(sulfooxy)oxan-3-yl]oxy}-3-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-4,5-dihydroxy |
66414 |
pubchem |
| NAD metabolism, sirtuins and aging |
R-ALL-374935 |
0 |
Olaparib |
23725625 |
pubchem |
| Transport of small molecules |
R-HSA-382551 |
0 |
AdoMet |
68374 |
pubchem |
| SLC-mediated transmembrane transport |
R-HSA-425407 |
0 |
AdoMet |
68374 |
pubchem |